| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14740338.2016.1131817 |
| P8608 | Fatcat ID | release_cbf36mizgjfsxg5iwhptukiaky |
| P698 | PubMed publication ID | 26715118 |
| P2093 | author name string | Jon O Ebbert | |
| Melissa A Little | |||
| P2860 | cites work | Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis | Q24647475 |
| Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials | Q26801320 | ||
| Emerging drugs for the treatment of tobacco dependence: 2014 update | Q28236453 | ||
| Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation | Q28250054 | ||
| Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study | Q28267175 | ||
| Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis | Q28303682 | ||
| Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. | Q30923804 | ||
| Psychological mediators of bupropion sustained-release treatment for smoking cessation | Q33887773 | ||
| Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial | Q33997418 | ||
| Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. | Q34014716 | ||
| Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial. | Q34253442 | ||
| Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation | Q34347042 | ||
| Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm | Q34425063 | ||
| Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial | Q34508532 | ||
| Varenicline, smoking cessation, and neuropsychiatric adverse events | Q34546833 | ||
| Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy? | Q34880982 | ||
| Effect of Stress and Bupropion on Craving, Withdrawal Symptoms, and Mood in Smokers | Q35012340 | ||
| Tobacco dependence and the nicotine patch. Clinical guidelines for effective use | Q35222945 | ||
| Transdermal Nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation | Q35339124 | ||
| Effects of high dose transdermal nicotine replacement in cigarette smokers | Q36116552 | ||
| Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis | Q36711713 | ||
| Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety | Q37348540 | ||
| Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. | Q37649417 | ||
| Adverse effects and tolerability of medications for the treatment of tobacco use and dependence | Q37818134 | ||
| High-dose transdermal nicotine replacement for tobacco cessation | Q38200985 | ||
| Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial | Q38405702 | ||
| Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. | Q38405712 | ||
| Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study | Q38427130 | ||
| Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial | Q38427154 | ||
| A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder | Q38469664 | ||
| High-dose nicotine patch therapy. Percentage of replacement and smoking cessation | Q39471094 | ||
| Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence | Q40526289 | ||
| Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence | Q43067207 | ||
| Reassessing the safety of varenicline | Q44118775 | ||
| Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo‐controlled trial of nicotine gum with 2‐year follow‐up | Q44602487 | ||
| Pharmacokinetics of a nicotine polacrilex lozenge | Q44631535 | ||
| Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study | Q45300134 | ||
| Antidepressant treatment and smoking cessation in bipolar disorder. | Q45995762 | ||
| Transdermal nicotine and smoking behavior in psychiatric patients | Q46284924 | ||
| Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial | Q46310193 | ||
| Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study | Q46843223 | ||
| Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers | Q46921505 | ||
| Increasing the dose of varenicline in patients who do not respond to the standard dose | Q48140562 | ||
| A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers | Q48460037 | ||
| A double-blind study evaluating the long-term safety of varenicline for smoking cessation | Q48472982 | ||
| A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation | Q48770780 | ||
| Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers | Q50085911 | ||
| Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. | Q50638329 | ||
| Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial | Q50916474 | ||
| Randomised controlled trial of nasal nicotine spray in smoking cessation | Q52264959 | ||
| Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial | Q53229883 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 333-341 | |
| P577 | publication date | 2015-12-30 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | The safety of treatments for tobacco use disorder | |
| P478 | volume | 15 |
Search more.